

In addition, you will help shaping PokeAcell together with us, to establish a professional and cutting-edge cell therapy company.

PROTEIN SCAFFOLD OF A HEART SKIN
Our T cell therapy hold the promise of curative treatment in Melanoma and Merkel Cell Carcinoma – two of the most severe skin cancers today and with potential in several other indications. We are an experienced team of science and business leaders that founded PokeAcell with the vision to provide curative treatment to late stage cancer patients, where no treatment is available today.
PROTEIN SCAFFOLD OF A HEART TRIAL
PokeAcell is a newly establish biotech company with a proprietary technology for personalized T-cell therapy preparing for a phase I trial in melanoma.

Indrykket 11. februar 2021 Join a new biotech developing curative cell therapy to late stage cancerĪre you dreaming of taking part in the shaping of a new biotech company and developing curative treatment to cancer? Are you highly experienced in protein conjugation, purification and protein stability strategies from biotech or large pharma and want to use your capacity to catalyze a new cell therapy to cancer? Then read on! About PokeAcell
